Clinical Trial Update: Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a four-drug combination—fluorouracil, leucovorin, gemcitabine, and cisplatin—for metastatic or unresectable adenocarcinoma of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urachal Cancer
• Urethral Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• Leucovorin (folinic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bladder Cancer, Urethral Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING